The brain care score, developed at the McCance Center for Brain Health, condenses twelve modifiable factors into a single number: four physical measures (blood pressure, hemoglobin A1c, cholesterol, and body mass index), five lifestyle behaviors (nutrition, alcohol intake, smoking, physical activity, and sleep), and three social-emotional dimensions (stress, relationships, and meaning in life). In the UK Biobank adaptation used here, the score ranges up to 19 points, with higher values indicating better brain care. Previous studies have linked higher scores to favorable neuroimaging markers and reduced risks of dementia, stroke, and late-life depression. What remained unknown was whether the score also tracks with the fine-grained architecture of the retina, an outgrowth of the central nervous system that shares vascular, metabolic, and inflammatory biology with the brain.

To find out, the team led by investigators at The Chinese University of Hong Kong analyzed optical coherence tomography (OCT) scans from 28,657 UK Biobank participants aged 40 to 69. OCT is a non-invasive imaging technique that uses light interference to map retinal layers at micrometer resolution, and the researchers examined eight distinct layers plus overall macular thickness. After rigorous quality control and statistical adjustment for age, sex, ethnicity, education, deprivation, cardiovascular disease history, refractive error, and intraocular pressure, a clear pattern emerged: each 5-point increase in the brain care score was associated with thicker retinal nerve fiber layer, thicker ganglion cell–inner plexiform layer, thicker photoreceptor segments, and greater average macular thickness.

The effect sizes are small in absolute terms—a few tenths of a micrometer per 5-point score increase, translating to roughly 1.2 percent difference in nerve fiber layer thickness and about half a percent for the ganglion cell layer relative to cohort means. The researchers are careful to stress that these are population-level structural differences, not differences an ophthalmologist could detect in a single patient or act on clinically. Yet the pattern was remarkably consistent. Participants in the lowest score quartile had significantly thinner layers across the board compared with those in the highest quartile, all trend tests were highly significant, and the findings held up in sensitivity analyses that accounted for nonlinear aging effects, restricted the sample to European participants, and replicated the associations using repeat OCT visits years later.

Perhaps the most provocative result concerns retinal biological age. The team trained a support vector machine on 60 OCT-derived structural metrics from thousands of healthy participants to predict chronological age from retinal structure alone, then defined an OCT age gap as the bias-corrected predicted age minus actual age. Positive values indicate a retina that looks older than it should. After full adjustment, each 5-point increase in brain care score was associated with a 0.326-year reduction in this retinal age gap, with the mean gap falling progressively from 0.39 years in the lowest score quartile to −0.08 years in the highest. In other words, people who take better care of their brains carry retinas that read as younger on a machine-learning clock.

Dissecting the score into its components revealed where the signal lives. The physical and lifestyle domains drove the associations, while the social-emotional domain showed no independent link to retinal structure. Favorable blood pressure, hemoglobin A1c, and body mass index were each tied to thicker specific layers and a smaller retinal age gap, with effects on the age gap ranging from about a quarter to nearly half a year. Non-smoking, moderate alcohol intake, regular aerobic exercise, and at least seven hours of nightly sleep each contributed modest reductions in retinal biological age. Interestingly, total cholesterol below 190 milligrams per deciliter was actually associated with a slightly larger retinal age gap, echoing a growing literature on the complex, sometimes U-shaped relationships between lipids and neurological health.

To probe the biology behind these correlations, the researchers turned to metabolomics. For a subset of 14,656 participants with nuclear magnetic resonance profiling of 249 plasma biomarkers, they ran exploratory mediation analyses asking whether circulating metabolites statistically carry part of the association between brain care score and retinal thickness. The candidate pathways that emerged centered on lipid metabolism, unsaturated fatty acids, and branched-chain amino acids. One principal component reflecting HDL-enriched lipid profiles mediated a small fraction of the association with nerve fiber and ganglion cell layer thickness, while another dominated by omega-3 polyunsaturated fatty acids showed positive indirect effects on photoreceptor layer thickness—a plausible finding given that docosahexaenoic acid, the dominant long-chain fatty acid in photoreceptor outer-segment membranes, is essential for photoreceptor function.

The authors are appropriately cautious about these mediation results. Because the brain care score, the metabolites, and the retinal measurements were all captured at the same point in time, no temporal ordering can be established, and the indirect-effect estimates cannot confirm genuine biological causation. The principal components themselves may be sample-dependent, and the proportion of the total effect explained by any single metabolic pattern was modest—ranging from under 3 percent to about 11 percent. Still, the convergence on lipid and amino acid pathways is biologically coherent: excess branched-chain amino acids have been implicated in oxidative stress and inflammation in animal models of diabetic retinopathy, and lipoprotein subclass composition has repeatedly surfaced in studies of age-related macular degeneration.

The broader significance of the study lies in what it says about the retina as a sentinel organ. Thinner retinal nerve fiber and ganglion cell layers have previously been linked to cognitive decline, reduced brain volumes, Alzheimer’s disease, and incident dementia, and photoreceptor thinning has been associated with morbidity and mortality. By showing that a practical, modifiable brain health index tracks with both retinal structure and a machine-learned retinal age, the findings reinforce the idea that the same vascular and metabolic forces that shape brain aging also leave fingerprints in the eye—fingerprints that a routine OCT scan, already common in eye clinics, can capture.

Limitations remain, and the researchers enumerate them candidly. The observational design leaves room for residual confounding, the cohort’s healthier-than-average volunteers and predominantly European ancestry may limit generalizability, and the OCT-based age clock correlates only moderately with chronological age, meaning it captures just one facet of retinal aging. The brain care score itself is still a prototype awaiting systematic refinement. What the study delivers is a hypothesis-generating map: a demonstration that brain care and retinal health travel together, that specific metabolic pathways plausibly connect them, and that longitudinal studies with repeated measurements should now test whether improving one’s brain care score actually slows the thinning of the retina—and, by extension, perhaps the aging of the brain behind it.

Subject of Research: Associations between the brain care score and retinal layer thickness and retinal biological age in the UK Biobank

Article Title: Brain care score and retinal health: structural and metabolic insights from the UK Biobank

Article References: Yu, J., Zhang, Y., Gao, Y. L., Ho, M., Kam, K. W., Gong, B., Young, A. L., Pang, C. P., Tham, C. C., Yam, J. C., & Chen, L. J. (2026). Brain care score and retinal health: structural and metabolic insights from the UK Biobank. GeroScience. https://doi.org/10.1007/s11357-026-02579-z

Image Credits: AI Generated

DOI: 10.1007/s11357-026-02579-z

Keywords: brain care score, retina, optical coherence tomography, UK Biobank, retinal biological age, metabolomics, macular thickness, neurodegeneration, lipid metabolism, omega-3 fatty acids, GeroScience, brain health

The team, led by ophthalmology researchers at the Eye Institute of Fudan University in Shanghai, quantified systemic aging using three complementary instruments. The first was PhenoAge acceleration, a measure derived from clinical biomarkers that estimates how much faster a person’s physiology is aging compared with their chronological peers. The second was age acceleration calculated by the Klemera-Doubal method, another biomarker-based biological age algorithm with a long track record in aging research. The third was a frailty index, a cumulative score built from deficits across health domains that captures the loss of physiological reserve characteristic of advanced aging. Each of these measures tells a slightly different story about aging, and the researchers wanted to know whether all of them converged on the same retinal signature.

That signature turned out to be strikingly consistent. Across all three aging metrics, higher biological age acceleration and greater frailty were associated with reduced macular thickness, with the effect spanning every inner retinal subfield measured by optical coherence tomography. The standardized effect sizes ranged from −1.386 to −0.421, and all associations remained highly significant after correction for multiple comparisons, with false discovery rate adjusted P values below 0.001. In practical terms, people whose bodies were aging faster than their birthdays implied tended to have measurably thinner retinas, and the relationship held whether aging was defined by molecular biomarkers, composite algorithms, or the clinical syndrome of frailty.

Optical coherence tomography, the imaging technology behind these measurements, deserves a moment of explanation. Originally described in Science in 1991, OCT uses low-coherence interferometry to generate cross-sectional images of biological tissue with micrometer-scale resolution. In the UK Biobank, tens of thousands of participants underwent retinal OCT scanning, producing an enormous, standardized dataset of retinal layer thicknesses. Because the retina is embryologically part of the central nervous system and shares vascular and metabolic characteristics with the brain, changes in its structure have been proposed as noninvasive biomarkers for neurological and systemic disease. Previous work has linked retinal thinning to cardiovascular risk, Alzheimer disease, and early age-related macular degeneration, but the broader question of how whole-body aging states map onto retinal structure had remained poorly characterized.

The most technically ambitious part of the new study involved the plasma metabolome. Blood samples collected from participants between 2006 and 2010 had been profiled using nuclear magnetic resonance spectroscopy, a platform that quantifies hundreds of circulating metabolites, including lipoprotein subclasses, fatty acids, amino acids, and glycolysis-related markers. From this high-dimensional data, the researchers derived metabolic signatures of aging using elastic net regression, a machine learning technique that selects sparse, predictive combinations of variables while guarding against overfitting. The resulting metabolomic aging signatures were then tested as statistical mediators of the relationship between biological aging and retinal thinning.

The mediation results were the study’s headline finding. Metabolic signatures accounted for 81.14 percent of the association between PhenoAge acceleration and macular thickness, 19.92 percent of the association for Klemera-Doubal method age acceleration, and 32.27 percent of the association for the frailty index, with all mediation effects significant after FDR correction. These proportions are remarkable, particularly for PhenoAge, and they suggest that circulating metabolites are not merely passive bystanders in the aging process but plausible conduits through which systemic senescence reaches the neurosensory retina. The retina is among the most metabolically demanding tissues in the body, with photoreceptors and the retinal pigment epithelium locked in a tightly coupled metabolic ecosystem that depends on glucose, lactate shuttling, and mitochondrial oxidative metabolism. Disruption of systemic metabolic homeostasis, the authors argue, is therefore well positioned to leave structural fingerprints in retinal tissue.

The study also incorporated the exposome, the concept introduced by cancer epidemiologist Christopher Wild in 2012 to describe the totality of environmental exposures an individual experiences across a lifetime. The researchers assembled exposome factors from phenotypic data covering lifestyle, diet, air pollution, and mental health. Their integrative analyses showed that adverse exposome profiles, including tobacco exposure, poor diet, air pollution, and negative psychosocial states such as loneliness and depression, were each correlated with reduced macular thickness. More importantly, systemic aging and metabolic dysregulation emerged as significant statistical intermediaries within these multidimensional pathways, meaning that environmental burdens appear to translate into retinal change at least partly by accelerating biological aging and reshaping the circulating metabolome.

This framing has implications that extend well beyond ophthalmology. If the retina reflects the convergence of environmental stress, metabolic dysregulation, and biological aging, then a routine retinal scan could in principle serve as a rapid, noninvasive readout of an individual’s cumulative aging trajectory. The findings align with a growing body of work on retinal oculomics, including phenome-wide analyses of UK Biobank OCT images that have linked ocular measurements to systemic health, and epidemiological studies showing that ambient air pollution is associated with retinal thinning and age-related macular degeneration. The new study unifies these threads by proposing an explicit causal architecture in which exposures act on aging biology, aging biology acts on metabolism, and metabolism acts on the retina.

The authors are careful about what their statistics can and cannot show. Mediation analysis in observational data identifies statistical intermediaries, not proven causal mechanisms, and the cross-sectional design of the UK Biobank baseline assessments means that temporal ordering cannot be fully established. The metabolomic platform used, while comprehensive for lipids and small molecules, does not capture every biologically relevant compound, and the elastic net signatures are predictive composites rather than single causal metabolites. Residual confounding by socioeconomic factors, which shape both exposome and health outcomes, remains a persistent challenge in cohort studies of this kind. Nevertheless, the sheer scale of the cohort, the consistency of the associations across three independent aging metrics, and the rigorous multiple-comparison correction lend considerable weight to the central conclusion.

For the aging research community, the study adds the retina to the growing list of organs whose structural integrity tracks systemic biological age, and it elevates plasma metabolism to the status of a key correlate of neurosensory retinal health. For clinicians, it hints at a future in which retinal imaging, already fast and inexpensive, might help identify people whose bodies are aging faster than their years, potentially guiding earlier interventions on smoking, diet, air quality, and psychosocial wellbeing. And for the public, the message is a vivid one: the same exposures that wear down the heart, the brain, and the metabolism may also be quietly etched into the tissue that lets you read this page. The eye, it seems, does not only take in the world; it keeps a record of what the world has done to us.

Subject of Research: Associations between systemic biological aging, frailty, exposome factors, plasma metabolomics, and retinal structural changes in the UK Biobank

Article Title: Association of systemic aging and frailty with retinal alterations: insights from an integrated exposome and metabolome framework

Article References: Chen, T., Wang, D., Ma, Y., Ye, Y., Wang, X., Lei, Y., Zhou, X., & Zhao, J. (2026). Association of systemic aging and frailty with retinal alterations: insights from an integrated exposome and metabolome framework. GeroScience. https://doi.org/10.1007/s11357-026-02572-6

Image Credits: AI Generated

DOI: 10.1007/s11357-026-02572-6

Keywords: retinal oculomics, biological aging, frailty, plasma metabolomics, exposome, UK Biobank, macular thickness, optical coherence tomography, PhenoAge, mediation analysis, GeroScience, aging biomarkers